Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BYBiomedicines

Regenerative Strategies for Osteoporotic Craniomaxillofacial Bone Defects: Evidence, Translational Gaps, and Future Directions

Related

  1. Advancing regenerative biomaterials and translational strategies in orthopaedic traumatology.
    Vu Le, J Tracy Watson, Sara McBride-Gagyi +4
    OTA international : the open access journal of orthopaedic traumaPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthSurgery & anaesthesiaEurope PMCDOAJPMC
  2. Regenerative Medicine in the Management of Musculoskeletal Pain: Mechanisms, Clinical Applications, and Future Directions.
    Salah N El-Tallawy, Joseph V Pergolizzi, Tariq A Alzahrani +8
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Precision Orthobiologics for Chronic Musculoskeletal Pain: Matching Biology, Pathology, and Patient Phenotype-A Narrative Review of Current Evidence and Future Directions in Regenerative Pain Medicine.
    Giuliano Lo Bianco, Douglas P Beall, Sudhir Diwan +8
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Transformer models in cardiovascular medicine: current applications, translational challenges, and future directions.
    Yang Yan, Gaoxiang Li, Taiwei Chen +5
    Frontiers in artificial intelligencePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Restrictive vs. liberal blood transfusion strategies in Africa: clinical outcomes, resource stewardship, and future directions
    Emmanuel Ifeanyi Obeagu
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{anon2026regenerative,
  title = {{Regenerative Strategies for Osteoporotic Craniomaxillofacial Bone Defects: Evidence, Translational Gaps, and Future Directions}},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701715},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Regenerative Strategies for Osteoporotic Craniomaxillofacial Bone Defects: Evidence, Translational Gaps, and Future Directions
PY  - 2026
DA  - 2026/09/29
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701715
SN  - 2227-9059
ER  -